Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers

Saito, Takuro, Nishikawa, Hiroyoshi, Wada, Hisashi, Nagano, Yuji, Sugiyama, Daisuke, Atarashi, Koji, Maeda, Yuka, Hamaguchi, Masahide +14 more·2016·Nature Medicine
DOI 10.1038/nm.4086

Cited by (874)

Items 801–874 of 874

  1. Spatial Technologies: A Game Changer for Studying the Tumor Microenvironment
    Ren Yuan Lee, Mai Chan Lau, Denise L M Goh, Felicia Yu Ting Wee, Jeffrey Chun Tatt Lim, Joe Poh Sheng YEONG · 2025 · Springer eBooks
  2. Expression Characteristics, Prognostic Value, and Immune-Related Analysis of PPP2R1A in Lung Adenocarcinoma
    Mingyou Dong, HU Yuhong, Shanshan Xiao, Pei Ouyang, Yuejiao Huang, Yawen Li, Xin Zhang, Mei Fei, Lusheng Liao, Qinqin Long · 2025 · Research Square
  3. Additional file 7 of Identification and validation of methylated differentially expressed miRNAs and immune infiltrate profile in EBV-associated gastric cancer
    Zhu, Mansheng, Liang, Qixiang, Chen, Tao, Kong, Qian, Ye, Gengtai, Yu, Shitong, Li, Xunjun, He, Qinglie, Liu, Hao, Hu, Yanfeng et al. · 2021 · Figshare
  4. Additional file 1 of In situ analysis of CCR8+ regulatory T cells in lung cancer: suppression of GzmB+ CD8+ T cells and prognostic marker implications
    Hayashi, Yoshinori, Azumi Ueyama, Funaki, Soichiro, Koichi Jinushi, Higuchi, Naoko, Hitomi Morihara, Michinari Hirata, Yoji Nagira, Saito, Takuro, Kawashima, Atsunari et al. · 2024 · Figshare
  5. Additional file 9 of Identification and validation of methylated differentially expressed miRNAs and immune infiltrate profile in EBV-associated gastric cancer
    Zhu, Mansheng, Liang, Qixiang, Chen, Tao, Kong, Qian, Ye, Gengtai, Yu, Shitong, Li, Xunjun, He, Qinglie, Liu, Hao, Hu, Yanfeng et al. · 2021 · Figshare
  6. Additional file 1 of Molecular subtypes based on cuproptosis-related genes and tumor microenvironment infiltration characterization in ovarian cancer
    Zhang, Jingjing, Lu, Miao, Xu, Haoya, Ren, Fang, Zhu, Liancheng · 2022 · Figshare
  7. Additional file 2 of CD4+CCR8+ Tregs in ovarian cancer: a potential effector Tregs for immune regulation
    Liu, Shuna, Tao, Ziqi, 娄鉴芳, Rong Li, Fu, Xin, Xu, Juan, Wang, Ting, Zhang, Lei, Shang, Wenwen, Yepeng Mao et al. · 2024 · Figshare
  8. Additional file 4 of CD4+CCR8+ Tregs in ovarian cancer: a potential effector Tregs for immune regulation
    Liu, Shuna, Tao, Ziqi, 娄鉴芳, Li, Rong, Fu, Xin, Xu, Juan, Wang, Ting, Zhang, Lei, Shang, Wenwen, Yepeng Mao et al. · 2024 · Figshare
  9. Additional file 5 of Identification and validation of methylated differentially expressed miRNAs and immune infiltrate profile in EBV-associated gastric cancer
    Zhu, Mansheng, Liang, Qixiang, Chen, Tao, Kong, Qian, Ye, Gengtai, Yu, Shitong, Li, Xunjun, He, Qinglie, Liu, Hao, Hu, Yanfeng et al. · 2021 · Figshare
  10. Additional file 3 of Association between effector-type regulatory T cells and immune checkpoint expression on CD8+ T cells in malignant ascites from epithelial ovarian cancer
    Sato, Sho, Matsushita, Hirokazu, Daisuke Shintani, Kobayashi, Yukari, Fujieda, Nao, Yabuno, Akira, Tadaaki Nishikawa, Fujiwara, Keiichi, Kakimi, Kazuhiro, Hasegawa, Kosei · 2022 · Figshare
  11. Additional file 2 of Association between effector-type regulatory T cells and immune checkpoint expression on CD8+ T cells in malignant ascites from epithelial ovarian cancer
    Sato, Sho, Matsushita, Hirokazu, Daisuke Shintani, Kobayashi, Yukari, Fujieda, Nao, Yabuno, Akira, Tadaaki Nishikawa, Fujiwara, Keiichi, Kakimi, Kazuhiro, Hasegawa, Kosei · 2022 · Figshare
  12. Additional file 2 of In situ analysis of CCR8+ regulatory T cells in lung cancer: suppression of GzmB+ CD8+ T cells and prognostic marker implications
    Hayashi, Yoshinori, Azumi Ueyama, Funaki, Soichiro, Koichi Jinushi, Higuchi, Naoko, Hitomi Morihara, Michinari Hirata, Yoji Nagira, Saito, Takuro, Kawashima, Atsunari et al. · 2024 · Figshare
  13. Additional file 2 of Identification and validation of methylated differentially expressed miRNAs and immune infiltrate profile in EBV-associated gastric cancer
    Zhu, Mansheng, Liang, Qixiang, Chen, Tao, Kong, Qian, Ye, Gengtai, Yu, Shitong, Li, Xunjun, He, Qinglie, Liu, Hao, Hu, Yanfeng et al. · 2021 · Figshare
  14. Additional file 1 of The tumor-stroma ratio in giant cell tumor of bone: associations with the immune microenvironment and responsiveness to denosumab treatment
    Wu, Hai-Lin, Wang, Xiao-Bin, Li, Jing, Zheng, Bo-Wen · 2024 · Figshare
  15. Additional file 5 of CD4+CCR8+ Tregs in ovarian cancer: a potential effector Tregs for immune regulation
    Liu, Shuna, Tao, Ziqi, 娄鉴芳, Li, Rong, Fu, Xin, Xu, Juan, Wang, Ting, Zhang, Lei, Shang, Wenwen, Yepeng Mao et al. · 2024 · Figshare
  16. Additional file 6 of Identification and validation of methylated differentially expressed miRNAs and immune infiltrate profile in EBV-associated gastric cancer
    Zhu, Mansheng, Liang, Qixiang, Chen, Tao, Kong, Qian, Ye, Gengtai, Yu, Shitong, Li, Xunjun, He, Qinglie, Liu, Hao, Hu, Yanfeng et al. · 2021 · Figshare
  17. Additional file 1 of Predicting response to immunotherapy in gastric cancer via assessing perineural invasion-mediated inflammation in tumor microenvironment
    Li, Xunjun, Wang, Yiyun, ZhongYa Zhai, Qingyi Mao, Dianjie Chen, Luxi Xiao, Xu, Shuai, Wu, Qilin, Chen, Keming, Qiantong Hou et al. · 2023 · Figshare
  18. Additional file 8 of Identification and validation of methylated differentially expressed miRNAs and immune infiltrate profile in EBV-associated gastric cancer
    Zhu, Mansheng, Liang, Qixiang, Chen, Tao, Kong, Qian, Ye, Gengtai, Yu, Shitong, Li, Xunjun, He, Qinglie, Liu, Hao, Hu, Yanfeng et al. · 2021 · Figshare
  19. Additional file 3 of CD4+CCR8+ Tregs in ovarian cancer: a potential effector Tregs for immune regulation
    Liu, Shuna, Tao, Ziqi, 娄鉴芳, Rong Li, Fu, Xin, Xu, Juan, Wang, Ting, Zhang, Lei, Shang, Wenwen, Yepeng Mao et al. · 2024 · Figshare
  20. Additional file 1 of Identification and validation of methylated differentially expressed miRNAs and immune infiltrate profile in EBV-associated gastric cancer
    Zhu, Mansheng, Liang, Qixiang, Chen, Tao, Kong, Qian, Ye, Gengtai, Yu, Shitong, Li, Xunjun, He, Qinglie, Liu, Hao, Hu, Yanfeng et al. · 2021 · Figshare
  21. Additional file 10 of Identification and validation of methylated differentially expressed miRNAs and immune infiltrate profile in EBV-associated gastric cancer
    Zhu, Mansheng, Liang, Qixiang, Chen, Tao, Kong, Qian, Ye, Gengtai, Yu, Shitong, Li, Xunjun, He, Qinglie, Liu, Hao, Hu, Yanfeng et al. · 2021 · Figshare
  22. Additional file 4 of Identification and validation of methylated differentially expressed miRNAs and immune infiltrate profile in EBV-associated gastric cancer
    Zhu, Mansheng, Liang, Qixiang, Chen, Tao, Kong, Qian, Ye, Gengtai, Yu, Shitong, Li, Xunjun, He, Qinglie, Liu, Hao, Hu, Yanfeng et al. · 2021 · Figshare
  23. Additional file 5 of In situ analysis of CCR8+ regulatory T cells in lung cancer: suppression of GzmB+ CD8+ T cells and prognostic marker implications
    Hayashi, Yoshinori, Azumi Ueyama, Funaki, Soichiro, Koichi Jinushi, Higuchi, Naoko, Hitomi Morihara, Michinari Hirata, Yoji Nagira, Saito, Takuro, Kawashima, Atsunari et al. · 2024 · Figshare
  24. Additional file 4 of Association between effector-type regulatory T cells and immune checkpoint expression on CD8+ T cells in malignant ascites from epithelial ovarian cancer
    Sato, Sho, Matsushita, Hirokazu, Daisuke Shintani, Kobayashi, Yukari, Fujieda, Nao, Yabuno, Akira, Tadaaki Nishikawa, Fujiwara, Keiichi, Kakimi, Kazuhiro, Hasegawa, Kosei · 2022 · Figshare
  25. Additional file 12 of Identification and validation of methylated differentially expressed miRNAs and immune infiltrate profile in EBV-associated gastric cancer
    Zhu, Mansheng, Liang, Qixiang, Chen, Tao, Kong, Qian, Ye, Gengtai, Yu, Shitong, Li, Xunjun, He, Qinglie, Hao Liu, Hu, Yanfeng et al. · 2021 · Figshare
  26. Additional file 3 of Identification and validation of methylated differentially expressed miRNAs and immune infiltrate profile in EBV-associated gastric cancer
    Zhu, Mansheng, Liang, Qixiang, Chen, Tao, Kong, Qian, Ye, Gengtai, Yu, Shitong, Li, Xunjun, He, Qinglie, Liu, Hao, Hu, Yanfeng et al. · 2021 · Figshare
  27. Additional file 13 of Identification and validation of methylated differentially expressed miRNAs and immune infiltrate profile in EBV-associated gastric cancer
    Zhu, Mansheng, Liang, Qixiang, Chen, Tao, Kong, Qian, Ye, Gengtai, Yu, Shitong, Li, Xunjun, He, Qinglie, Liu, Hao, Hu, Yanfeng et al. · 2021 · Figshare
  28. Additional file 14 of Identification and validation of methylated differentially expressed miRNAs and immune infiltrate profile in EBV-associated gastric cancer
    Zhu, Mansheng, Liang, Qixiang, Chen, Tao, Kong, Qian, Ye, Gengtai, Yu, Shitong, Li, Xunjun, He, Qinglie, Liu, Hao, Hu, Yanfeng et al. · 2021 · Figshare
  29. Additional file 1 of Association between effector-type regulatory T cells and immune checkpoint expression on CD8+ T cells in malignant ascites from epithelial ovarian cancer
    Sato, Sho, Matsushita, Hirokazu, Daisuke Shintani, Kobayashi, Yukari, Fujieda, Nao, Yabuno, Akira, Tadaaki Nishikawa, Fujiwara, Keiichi, Kakimi, Kazuhiro, Hasegawa, Kosei · 2022 · Figshare
  30. Additional file 1 of Intratumoral regulatory T cells from colon cancer patients comprise several activated effector populations
    Louis Szeponik, Filip Ahlmanner, Patrik Sundström, William Carl Ivar Rodin, Gustavsson, Bengt, Bexe Lindskog, Elinor, Yvonne Wettergren, Marianne Quiding‐Järbrink · 2021 · Figshare
  31. Additional file 11 of Identification and validation of methylated differentially expressed miRNAs and immune infiltrate profile in EBV-associated gastric cancer
    Zhu, Mansheng, Liang, Qixiang, Chen, Tao, Kong, Qian, Ye, Gengtai, Yu, Shitong, Li, Xunjun, He, Qinglie, Liu, Hao, Hu, Yanfeng et al. · 2021 · Figshare
  32. Additional file 1 of CD4+CCR8+ Tregs in ovarian cancer: a potential effector Tregs for immune regulation
    Liu, Shuna, Tao, Ziqi, 娄鉴芳, Rong Li, Fu, Xin, Xu, Juan, Wang, Ting, Zhang, Lei, Shang, Wenwen, Yepeng Mao et al. · 2023 · Figshare
  33. Additional file 3 of In situ analysis of CCR8+ regulatory T cells in lung cancer: suppression of GzmB+ CD8+ T cells and prognostic marker implications
    Hayashi, Yoshinori, Azumi Ueyama, Funaki, Soichiro, Koichi Jinushi, Higuchi, Naoko, Hitomi Morihara, Michinari Hirata, Yoji Nagira, Saito, Takuro, Kawashima, Atsunari et al. · 2024 · Figshare
  34. Additional file 4 of In situ analysis of CCR8+ regulatory T cells in lung cancer: suppression of GzmB+ CD8+ T cells and prognostic marker implications
    Hayashi, Yoshinori, Azumi Ueyama, Funaki, Soichiro, Koichi Jinushi, Higuchi, Naoko, Hitomi Morihara, Michinari Hirata, Yoji Nagira, Saito, Takuro, Kawashima, Atsunari et al. · 2024 · Figshare
  35. Not aIL Treg-mediated suppress10n is equal
    David E. J. Klawon, Tyler Jacks · 2026 · Immunity
  36. Making sense of TILs : recommendations for morphological assessment of tumour‐infiltrating lymphocytes in gastro‐oesophageal carcinoma
    Ylva Weeda, Roberto Salgado, Filip Van Herpe, Daniel Genel Sur, Michael Vieth, Sherene Loi, Ahmad Pahlavan Tafti, Alexandros Hardas, Akira I. Hida, Amarpreet Bhalla et al. · 2026 · Histopathology
  37. Thrombosis-related gene signature predicts prostate cancer recurrence and immune therapy: insights from retrospective cohorts, bioinformatics, and experimental validation
    Yong Luo, Peixian Chen, Minyi Situ, Wei Zhuang, Jinxing Huang, B. WANG, Qiong Wang, Shengmeng Peng, Hai Huang · 2026 · Inflammation Research
  38. Biomaterial-mediated reactive oxygen species regulation for Cancer immunotherapy: Mechanisms and applications
    Shuning Liu, Run Zhang, Yiqi Jin, Zunzhen Ming, Xingguang Li, Huijing Xiang · 2026 · Coordination Chemistry Reviews
  39. Regulatory T cells in ovarian cancer: Insights into cancer immunotherapy
    Yueer Chang, Jianyu Yu, Zhixin Qiu, Juan Zhang, Zheng Yang, Jinan He, Na Li, Han Bing Wang · 2026 · Critical Reviews in Oncology/Hematology
  40. Novel fatty acid metabolism risk score model for guiding treatment in endometrial endometrioid cancer
    Xiaoxiao Xu, Qingmei Wu, Li Liu, Zhengwei Liang, Lieyang Li, Deqin Lu, Sha Lv · 2026 · Scientific Reports
  41. Impact direct du VEGF-A sur le microenvironnement immunitaire en situation tumorale : modulation par les anti-angiogéniques
    Thibault Voron · 2019
  42. Caractérisation de l’infiltrat lymphocytaire cd4 et étude des réponses immunitaires dans le cancer colorectal
    Marie Kroemer · 2018
  43. A Study on the Role of the Intestinal MAdCAM-1/alpha4beta7 Axis in Tumor Immunosurveillance During PD-1 Blockade
    Conrad Rauber · 2019 · theses.fr (ABES)
  44. The Immune Modulation Role of Low Dosage of Cyclosporin-A (LdCsA) in the Antitumor Response of the Adaptive Immune System
    Camila Flores Torres · 2019 · theses.fr (ABES)
  45. Contribution à l'identification de marqueurs de la réponse des carcinomes bronchiques non à petites cellules aux immunothérapies
    Florian Guisier · 2019
  46. Activation des lymphocytes T gamma delta dans les cancers
    Chloé Laplagne · 2020 · theses.fr (ABES)
  47. Effet anti-tumoral du GTN +/- doxorubicine dans le cancer du sein triple négatif : implication du système immunitaire
    Nesrine Mabrouk · 2021 · theses.fr (ABES)
  48. Effets toxiques et immunogènes des histones extracellulaires sur les cellules endothéliales au cours du syndrome de lyse tumorale
    Marine Arnaud · 2022 · theses.fr (ABES)
  49. The Evolving Landscape of the Colorectal Cancer Vaccines: From Biological Mechanisms to Translational Therapeutics
    Sabrina Brigitta Valerie Setiono, Grace L. A. Turalaki, Trina Ekawati Tallei · 2026 · Heca Journal of Applied Sciences
  50. HVEM : une nouvelle cible prometteuse d'immunothérapie anti-cancéreuse
    Clémence Demerle · 2023
  51. Influence des neurones sensoriels sur la croissance tumorale et sur la réponse immunitaire anti-tumorale associée
    Ugo Mardelle · 2024
  52. Aspirin Enhances Chemosensitivity of Colorectal Cancer Cells by Downregulating FOXP3 to Inhibit ABCB1 Expression
    Yi-Xiao Lu, J M Chen, Xiao-Dan Wang, T Wang, Bing-Sheng Liu, Yi-xian CHENG, Guodong Cao, Ting Li · 2026 · Research Square
  53. Targeting regulatory T cells in gastrointestinal cancers: current status and future perspectives
    Koichi Jinushi, Takuro Saito, Yuichiro Doki · 2026 · International Journal of Clinical Oncology
  54. Systemic application of IL-33 for cancer immunoprevention and immunotherapy
    Jie Liu, Hongyan Wei, Zhenchu Feng, H S Sun, Y Zhang, Wenlong Chen, Xiaoshi Li, Chang Li, Y Zhang, Yixi Ke et al. · 2026 · Molecular Therapy
  55. SRSF3 determines T reg cell fate in antitumor immunity and autoimmunity
    Rong Jia, Guo J, Linyan Yan, Can Lin, Jun Jia, Jun Shao, Dunfang Zhang, Na Liu, WanJun Chen · 2026 · Science Advances
  56. Foxp3+/ CD4 + Cell Ratio in Primary Colorectal Cancer Predicts Opposite Prognoses Following Resection of Synchronous or Metachronous Liver Metastases
    Andriy V. Trailin, Esraa Ali, Sergii Pavlov, Wenjing Ye, Lenka Červenková, Ondřej Vyčítal, Filip Ambrożkiewicz, Miroslav Jiřík, Ondřej Daum, Václav Liška et al. · 2026 · Cancer Medicine
  57. Tumor-adapted regulatory T cells: Molecular reprogramming, immune suppression, and therapeutic targeting in cancer
    Mohammad Fayyad‐Kazan · 2026 · Molecular Biology Reports
  58. Selected Chemokines as Prognostic Biomarkers and Therapeutic Targets in Ovarian Cancer
    Anna Długaszek, Jacek Kabut, Małgorzata Domagała-Haduch, Anita Gorzelak-Magiera, Joanna Sadurska, Maria Laura-Morawiec, Aleksandra Mielczarek‐Palacz, Iwona Gisterek · 2026 · Current Issues in Molecular Biology
  59. From microbial detection to immune profiling: Analytical strategies for Fusobacterium nucleatum in colorectal cancer and liver metastasis
    Dan Zu, Yuping Zhu, Zhichao Ma, Junkai Xie, Weiping Chen, Yuehua Chen, Guiping Chen, Qinghua Yao, Wei Chen, Chao Xu · 2026 · TrAC Trends in Analytical Chemistry
  60. IL-6/JAK2/STAT3 axis mediates non-classical monocyte-induced Th17-like conversion of activated Tregs in acute myeloid leukemia patients
    Xiaoran Dai, Yuanling Zheng, Xu Liu, Ruoyu Huang, Mei Fu, Meijuan Zheng, Yuanhong Xu, Jianyao Huang, Lu Zong · 2026 · BMC Cancer
  61. Deciphering the colorectal tumor microenvironment: Interactions and targets for effective therapy
    Jingming Zhao, Chong Shi, Yu Du, Guofeng Li, Chengqiu Yan · 2026 · Biochemical Pharmacology
  62. Coordinated dynamics of circulating neutrophils, regulatory T lymphocytes, myeloid derived suppressor cells and distinct granulocytic subsets reveal a complex immune network in metastatic colorectal cancer
    Zafeiris Zafeiriou, Anna Koutoulaki, Despoina Aggouraki, Filippos Koinis, Nikolaos Vardakis, Alexandra Voutsina, Katerina Papadogiannaki, Konstantia Kotta, Eleni‐Kyriaki Vetsika, Dimitris Mavroudis et al. · 2026 · Frontiers in Oncology
  63. Regulatory T cells in the bladder cancer tumor microenvironment: mechanisms of immune suppression and therapeutic opportunities
    Yusuke Fukiage, Nodoka Okubo, Minekatsu Taga, Yohei Sato, Naoki Terada · 2026 · Frontiers in Molecular Biosciences
  64. CD47 and FOXP3+ Regulatory Immunity in Colorectal Cancer: A Conceptual Framework for Coordinated Immunosuppression
    Qijie Li, Anello Marcello Poma, Donghao Tang, Paola Vignali, Rossella Bruno, Elisabetta Macerola, Beatrice Fuochi, Clara Ugolini · 2026 · Cancers
  65. Molecular Mechanisms and Immune Regulation in Prostate Cancer: A Review
    Nigel P Murray · 2026 · International Journal of Molecular Sciences
  66. Gut Microbiome Modulation for Colorectal Cancer Therapy: Biomolecule‐Integrated Nanotherapeutic Strategies
    Poulami Sarkar, Somasri Shannigrahi, Olivia Sen, Subrata Adak, Priyanka Jana, Sreejan Manna · 2026 · ChemistrySelect
  67. Targeting immunosuppressive tumor microenvironment to combat immunotherapy resistance: From mechanistic insights to therapeutic strategies
    Pengfei Su, Yingjing Zhang, Tian Yu, 王元宇, 牟一平, Weiwei Jin · 2026 · International Immunopharmacology
  68. Spatial Treg niches and the therapeutic reprogramming of tumour tolerance in cancer
    Jhommara Bautista, Miranda Di Capua Delgado, Juliana Viteri-Recalde, Melanie Benítez-Núñez, David Ramírez-Sánchez, Andrés López-Cortés · 2026 · Frontiers in Cell and Developmental Biology
  69. Microbiome and Diseases: Colorectal Cancer
    Sebastian Zeißig, Florian Jokisch, Kenneth Peuker, Klaus‐Peter Janssen · 2026 · Springer eBooks
  70. In situ APMV-4 vaccination primes systemic response to subtherapeutic dosing of aCTLA-4 in colorectal carcinoma
    Yonina Bykov, Natalia Alonso Moreda, Naseem Sadek, Gloria O Dawodu, Srivatsan Swaminathan, Stephen T. Yeung, Daniel Lozano‐Ojalvo, Javier De Las Rivas, Jeffrey Alan Tomalka, Adolfo García‐Sastre et al. · 2026 · Journal for ImmunoTherapy of Cancer
  71. Why only 3 months? Immunological constraints on CAR-T therapy in gastrointestinal cancers
    Liping Zeng, Sheng Wei, Nan Chen, Xiangping Xie · 2026 · Frontiers in Immunology
  72. Regulatory T cells in lung adenocarcinoma: Mechanisms of immune escape, prognostic significance and therapeutic opportunities (Review)
    Lijuan Wang, Chenjin Ruan · 2026 · International Journal of Oncology
  73. ShenqiYichang decoction enhances colorectal cancer immune efficacy via IDO1 mediated reduction of Treg infiltration
    Yunhe Yang, Lingchang Li, Yuxi Fang, Zhou Yang, Rongtao Xue, Meng Gao, Lamei Zhou, Jian Zhang, Dongjian Zhang · 2026 · Journal of Ethnopharmacology
  74. Metabolic Dysfunction and T-Cell Exhaustion in Colorectal Cancer: Mechanisms, Microenvironment Remodeling, and Therapeutic Opportunities
    Jieun Jeon, Hye Suk Baek, Kibeom Park, Mee‐Na Park, Na Hyeon Heo, SoHyeon Cheon, Gahyeon Kim, Shin Kim · 2026 · International Journal of Molecular Sciences